What are the implications and recommended next steps for a patient with microarray results showing [hg38](1-22)x2, X(Y)x1, indicating a potential abnormality in the sex chromosomes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Microarray Results Interpretation: hg38x2(X,Y)x1

This microarray result indicates a normal male karyotype with two copies of each autosome (chromosomes 1-22) and one copy each of the X and Y chromosomes, representing a standard 46,XY male chromosomal complement. 1

Result Interpretation

The notation hg38x2(X,Y)x1 describes:

  • Two copies (x2) of all autosomes (chromosomes 1-22): This is the expected diploid state for autosomal chromosomes 1
  • One copy each (x1) of X and Y chromosomes: This represents a typical male sex chromosome complement 1
  • No copy number variations detected: The microarray did not identify any deletions or duplications across the genome 1

Clinical Implications

This is a normal result with no pathogenic findings requiring intervention. 1

Key Points:

  • No chromosomal abnormalities detected: The microarray shows normal copy numbers across all chromosomes, indicating no clinically significant deletions, duplications, or aneuploidies 1
  • Normal male sex chromosome complement: The presence of one X and one Y chromosome is consistent with typical male development 2
  • No further confirmatory testing needed: Since no abnormalities were identified, FISH confirmation or karyotyping is not indicated 2

Important Limitations to Communicate

While this result is reassuring, microarray analysis has inherent limitations that should be understood:

  • Cannot detect balanced rearrangements: Balanced translocations, inversions, or other structural rearrangements that don't alter copy number will not be detected 1
  • Limited sensitivity for low-level mosaicism: Mosaicism below approximately 20-30% may not be reliably detected by microarray 2
  • Cannot identify point mutations: Single nucleotide variants or small indels in specific genes are not detectable by this technology 1
  • Cannot determine parental origin: The test cannot identify uniparental disomy or determine which parent contributed specific chromosomal material 1

Recommended Next Steps

No additional genetic testing is indicated based on this normal microarray result. 1

Clinical Context Matters:

  • If clinical suspicion remains high for a specific genetic condition: Consider targeted gene sequencing, exome sequencing, or karyotyping if balanced rearrangements are suspected based on family history or phenotype 2
  • If sex chromosome mosaicism is clinically suspected: Traditional karyotyping may be more sensitive for detecting low-level mosaicism than microarray 2
  • If disorders of sex development are present: Despite normal microarray, targeted gene panel testing for DSD-related genes may be appropriate if phenotype is discordant with chromosomal sex 3

Common Pitfalls to Avoid

  • Do not assume microarray excludes all genetic conditions: Normal microarray does not rule out single gene disorders, balanced rearrangements, or low-level mosaicism 1
  • Do not order reflexive confirmatory testing: Since no abnormalities were detected, confirmation by FISH or karyotype is unnecessary and not cost-effective 2
  • Do not overlook clinical phenotype: If clinical features suggest a genetic condition despite normal microarray, pursue alternative testing strategies based on the specific clinical presentation 2

References

Guideline

Genetic Testing Methodologies

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.